Role of nitric oxide in atherosclerosis

Citation
D. Caillaud et al., Role of nitric oxide in atherosclerosis, PRESSE MED, 30(1), 2001, pp. 41-44
Citations number
21
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
PRESSE MEDICALE
ISSN journal
07554982 → ACNP
Volume
30
Issue
1
Year of publication
2001
Pages
41 - 44
Database
ISI
SICI code
0755-4982(20010113)30:1<41:RONOIA>2.0.ZU;2-C
Abstract
Atherosclerosis: Currently regarded as a multifactorial disease, atheroscle rosis involves several factor including: oxidized LDL, endothelial cells, m acrophages, imune cells, vascular smooth muscle cells. The endothelium appe ars to play a key role through the production of vasomotor, antiaggregate a nd leukocyte antiadhesion molecules. Nitric oxide: NO is one of the most important mediators of endothelial anti atherothrombotic functions. Loss of endothelial production, called "endothe lial dysfunction", i.e. loss of endothelial vasorelaxing, antiaggregate and keukocyte antiadhesion properties, could lead to increased fatty streak fo rmation and acute arterial events (thrombus formation, vascular spasm). Animal experiments: Although animal models strongly suggest a major role fo r NO in the pathophysiology of atherosclerosis, human studies with nitrates have been disappointing to date. The local effect of NO is probably closel y adapted to local conditions. Therefore, massive delivery of NO as is achi eved with nitrates could not repair endothelial dysfunction.